Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis

Silvia Casacuberta-Serra, Carme Costa, Herena Eixarch, María José Mansilla, Sergio López-Estévez, Lluís Martorell, Marta Parés, Xavier Montalban, Carmen Espejo, Jordi Barquinero

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)

Abstract

© 2016 Elsevier Inc. Previous work by our group showed that transferring bone marrow cells transduced with a self-antigen induced immune tolerance and ameliorated experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis (MS). We also found that following retroviral transduction of murine bone marrow (BM) cells, the majority of cells generated and transduced were myeloid-derived suppressor cells (MDSCs). Here, we aimed to determine whether purified antigen-expressing MDSCs have similar therapeutic effects than those of unfractionated BM, and to investigate their potential mechanisms. We performed phenotypic and functional analyses in these cells using the same animal model, and we used purified antigen-expressing MDSCs in preventive and therapeutic approaches. These cells exerted therapeutic effects similar to those of BM cells, which depended upon self-antigen expression. The majority of monocytic (M)-MDSCs expressed the immunosuppressive molecule programmed death ligand-1 (PD-L1), CD80, CD86 and MHC class II molecules. Additionally, the animals infused with antigen-expressing cells exhibited lower percentages of activated T cells and higher percentages of B cells with a regulatory phenotype (B220+ CD1dhigh CD5+) in the spleen than their respective controls. MDSCs expressing self-antigens, alloantigens or therapeutic transgenes are tolerogenic and can be exploited therapeutically in autoimmune diseases, transplantation and in gene therapy, respectively.
Original languageEnglish
Pages (from-to)50-60
JournalExperimental Neurology
Volume286
DOIs
Publication statusPublished - 1 Dec 2016

Keywords

  • Cell therapy
  • Experimental autoimmune encephalomyelitis
  • Immune tolerance
  • MHC class II
  • Multiple sclerosis
  • Myeloid-derived suppressor cells
  • PD-1
  • PD-L1
  • Regulatory B cells

Fingerprint Dive into the research topics of 'Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis'. Together they form a unique fingerprint.

  • Cite this

    Casacuberta-Serra, S., Costa, C., Eixarch, H., Mansilla, M. J., López-Estévez, S., Martorell, L., Parés, M., Montalban, X., Espejo, C., & Barquinero, J. (2016). Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis. Experimental Neurology, 286, 50-60. https://doi.org/10.1016/j.expneurol.2016.09.012